MedPath

Sciwind Biosciences APAC CO Pty. Ltd.

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:3
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (60.0%)
Phase 2
2 (40.0%)

XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults

Phase 1
Recruiting
Conditions
Obesity
Type 2 Diabetes Mellitus
Interventions
First Posted Date
2022-01-11
Last Posted Date
2024-06-28
Lead Sponsor
Sciwind Biosciences APAC CO Pty. Ltd.
Target Recruit Count
90
Registration Number
NCT05184322
Locations
🇦🇺

Q-Pharm Pty Ltd (AKA Nucleus Network Brisbane), Herston, Queensland, Australia

Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

Phase 2
Completed
Conditions
Obesity
Interventions
First Posted Date
2021-11-08
Last Posted Date
2023-08-21
Lead Sponsor
Sciwind Biosciences APAC CO Pty. Ltd.
Target Recruit Count
206
Registration Number
NCT05111912
Locations
🇦🇺

Paratus Clinical Research Brisbane, Brisbane, Queensland, Australia

Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy

Phase 2
Withdrawn
Conditions
COVID-19 Acute Respiratory Distress Syndrome
Interventions
Drug: Placebo
First Posted Date
2021-10-19
Last Posted Date
2023-08-21
Lead Sponsor
Sciwind Biosciences APAC CO Pty. Ltd.
Registration Number
NCT05083117
Locations
🇦🇷

Hospital Pirovano, Caba, Bs AS, Argentina

🇵🇪

Hospital Nacional Arzobispo Loayza, Lima, Peru

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants

Phase 1
Completed
Conditions
Type 2 Diabetes Mellitus
Nonalcoholic Steatohepatitis
Obesity
Interventions
Drug: Cohort A
Drug: Placebo A
Drug: Cohort B
Drug: Placebo B
First Posted Date
2020-05-15
Last Posted Date
2021-10-28
Lead Sponsor
Sciwind Biosciences APAC CO Pty. Ltd.
Target Recruit Count
64
Registration Number
NCT04389775
Locations
🇦🇺

Nucleus Network Pty Ltd, Melbourne, Victoria, Australia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.